Unfolded Protein Response: Silence without stress

  1. David J Young
  2. Nicholas R Guydosh  Is a corresponding author
  1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States

Cells, much like humans, must deal with a variety of stresses during their daily lives and react appropriately. In the absence of stress, it is also important that cells do not waste valuable resources on unnecessary responses.

Many proteins are synthesized by ribosomes that are bound to the membrane that surrounds the endoplasmic reticulum. The new proteins are then transported into the endoplasmic reticulum and folded into their correct final forms by molecular chaperones. However, many factors can cause unfolded or misfolded proteins to accumulate within the endoplasmic reticulum, which stresses it. In budding yeast, cells respond to such stress by expressing a transcription factor called Hac1p. This transcription factor is then transported to the nucleus, where it directs the expression of additional chaperones and other factors that can alleviate the stress (Cox and Walter, 1996; Mori et al., 1996). Many parts of this pathway are conserved across eukaryotes.

To guarantee a speedy response to endoplasmic reticulum stress, the messenger RNA (mRNA) for HAC1 is stored in a ‘silenced’ form in the cytoplasm where it can be quickly activated (Chapman and Walter, 1997; Kawahara et al., 1997). Now, in eLife, Rachael Di Santo, Soufiane Aboulhouda and David Weinberg of the University of California, San Francisco, report the results of elegant experiments that reveal more details about the nature of this silencing mechanism (Di Santo et al., 2016). In addition, they reveal an intricate fail-safe mechanism that ensures the destruction of any Hac1 protein that escapes silencing.

Most mRNA molecules have regions called introns that are removed in a process called splicing before the mRNA molecules are translated into proteins. HAC1 mRNA contains an atypical intron region that, in the absence of endoplasmic reticulum stress, undergoes base-pairing interactions with its own 5’ untranslated region (5’UTR; Sidrauski et al., 1996; Sidrauski and Walter, 1997). During endoplasmic reticulum stress, a protein senses the accumulation of unfolded proteins in the endoplasmic reticulum and removes the HAC1 intron in response. This process leads to the expression of the full-length Hac1 protein (Figure 1).

A functional Hac1 protein is made only if a block that prevents the initiation of translation is removed.

(Left) The translation of two mRNA exons (shown here in blue and purple) results in the production of the Hac1 protein. However, unspliced HAC1 mRNA contains an intron (orange) that, in the absence of endoplasmic reticulum stress, undergoes base-pairing interactions with its own 5’UTR. These interactions prevent most 40S ribosomes (blue oval) from loading onto the mRNA and initiating translation. When the endoplasmic reticulum becomes stressed (middle panel), Ire1 proteins (black triangles) splice out the intron. The spliced HAC1 mRNA can then be translated to form the full-length Hac1 protein, which triggers the unfolded protein response in order to relieve endoplasmic reticulum stress. (Right) In the absence of stress, some 40S ribosomes (blue ovals) manage to bypass the base-pairing interactions. In this case, the second exon is not translated, and a new sequence is found at the C-terminal end of the protein (red). This "degron tag" is recognized by a protein adaptor called Duh1, which targets Hac1 for ubiquitination – a process that involves the formation of a complex that also includes E2, Cul1 and Skp1 proteins. This ubiquitination marks the protein for rapid degradation by the proteasome.

Two main models have emerged that attempt to explain how the HAC1 mRNA is silenced by the base-pairing interactions between the intron and the 5’UTR. In the first model, the ribosomes are blocked by the interactions and cannot start translating the mRNA. In the second model the interactions cause the ribosomes to "stall" shortly after translation begins (Rüegsegger et al., 2001).

The stalled ribosome model was suggested by results from experiments that used a sucrose gradient to separate out the mRNA molecules that were being translated (and hence were attached to ribosomes) from those that were not. The results of these experiments showed that the majority of HAC1 mRNAs were present in the polysome region of the sucrose gradient (where the majority of translation takes place). However, these results were called into question by ribosome-footprint profiling experiments by Weinberg and others that showed that ribosomes were nearly absent from HAC1 transcripts in exponentially growing yeast (Weinberg et al., 2016). Through careful experimentation, Di Santo et al. reveal that the association of HAC1 mRNA with polysomes in sucrose gradients was an artifact caused by non-specific interactions. Thus it appears that HAC1 is silenced because ribosomes cannot start the translation process.

Di Santo et al. then uncovered an additional silencing mechanism that targets the Hac1 protein for destruction. In sucrose gradient experiments, mutating either the 5’UTR or the intron sequences in order to disrupt the base-pairing interaction resulted in the distribution of the mutant mRNAs being shifted to the polysome fractions. Although this suggested that translation could be initiated on these mutant transcripts, no protein was detectable. Further investigation revealed that the Hac1 protein synthesized from this mRNA variant was unstable because the intron encoded a 10-amino-acid tail that acted as a destruction signal (or “degron” tag).

Degron-mediated loss of the Hac1 protein occurs rapidly, making it difficult to record experimentally (Cox and Walter, 1996; Chapman and Walter, 1997; Kawahara et al., 1997). Di Santo et al. overcame this challenge with a number of clever biochemical tricks and genomic screens. These identified a previously unknown protein adapter, Duh1p, which recognizes the degron tag on Hac1 and targets the protein for ubiquitination, marking it for subsequent degradation by the proteasome.

The combination of inhibited translation initiation and accelerated protein degradation, both of which are dependent on the HAC1 intron, provides exquisite control of Hac1 protein levels in the absence of endoplasmic reticulum stress. This finding raises the question of whether Duh1p may regulate other proteins and whether similar adaptors exist to regulate other degron tags in the cell. While the Hac1 protein was already known for the unusual way in which it is regulated, these discoveries add yet another plot twist to this fascinating story.

References

Article and author information

Author details

  1. David J Young

    Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Nicholas R Guydosh

    Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    For correspondence
    nicholas.guydosh@nih.gov
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published:

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,315
    views
  • 151
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David J Young
  2. Nicholas R Guydosh
(2016)
Unfolded Protein Response: Silence without stress
eLife 5:e22073.
https://doi.org/10.7554/eLife.22073
  1. Further reading

Further reading

    1. Chromosomes and Gene Expression
    2. Microbiology and Infectious Disease
    Maruti Nandan Rai, Qing Lan ... Koon Ho Wong
    Research Article Updated

    Candida glabrata can thrive inside macrophages and tolerate high levels of azole antifungals. These innate abilities render infections by this human pathogen a clinical challenge. How C. glabrata reacts inside macrophages and what is the molecular basis of its drug tolerance are not well understood. Here, we mapped genome-wide RNA polymerase II (RNAPII) occupancy in C. glabrata to delineate its transcriptional responses during macrophage infection in high temporal resolution. RNAPII profiles revealed dynamic C. glabrata responses to macrophages with genes of specialized pathways activated chronologically at different times of infection. We identified an uncharacterized transcription factor (CgXbp1) important for the chronological macrophage response, survival in macrophages, and virulence. Genome-wide mapping of CgXbp1 direct targets further revealed its multi-faceted functions, regulating not only virulence-related genes but also genes associated with drug resistance. Finally, we showed that CgXbp1 indeed also affects fluconazole resistance. Overall, this work presents a powerful approach for examining host-pathogen interaction and uncovers a novel transcription factor important for C. glabrata’s survival in macrophages and drug tolerance.

    1. Chromosomes and Gene Expression
    2. Neuroscience
    Robyn D Moir, Emilio Merheb ... Ian M Willis
    Research Article

    Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.